WBIO — Wockhardt Bio AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Wockhardt Bio AG, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2018 March 31st	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	178	49.4	40.2	53.4	38.5
Net Total Accounts Receivable
Net Total Receivables	214	231	226	203	219
Total Inventory
Total Other Current Assets
Total Current Assets	468	345	315	322	308
Net Property, Plant And Equipment	112	120	120	125	121
Net Intangible Assets
Other Long Term Assets
Total Assets	744	646	647	641	632
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	260	278	294	310	317
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	491	421	395	351	351
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	254	226	252	290	281
Total Liabilities & Shareholders' Equity	744	646	647	641	632
Total Common Shares Outstanding